Sproxil & IBM Fight Drug Counterfeiting

Sproxil is using IBM technology to help the pharmaceutical industry reduce drug counterfeiting and allow consumers to verify the authenticity of prescriptions in seconds with their mobile phones. Through its collaboration with IBM, Sproxil is extending manufacturers' ability to view and analyse real time consumer data to detect and prevent drug counterfeiting in developing countries, where 25 to 50 percent of medicines are believed to be counterfeit, costing the industry $75 billion a year. With the collaboration, Sproxil also uses IBM's cloud service to provide clients with secure, reliable data access virtually anywhere.

Christian Harris is editor and publisher of BCW. Christian has over 20 years' publishing experience and in that time has contributed to most major IT magazines and Web sites in the UK. He launched BCW in 2009 as he felt there was a need for honest and personal commentary on a wide range of business computing issues. Christian has a BA (Hons) in Publishing from the London College of Communication.